Six Sigma represents an organized and evidence-based set of techniques for processing variations in manufacturing while searching for the root cause of defects and attempting to achieve better functional results. Six Sigma is particularly applicable to pharmaceutical processes and their improvement by introducing such applicable solutions as achieving better consistency of tablet weight, minimizing fill errors, analyzing the causes of errors in quality, improving laboratory methods, and enhancing performance characteristics of the equipment.
The approach has its techniques, such as DMAIC, SIPOC, Pareto analysis, fishbone diagrams, 5 Whys analysis, control charts, process capability tests, Failure Modes and Effects Analysis (FMEA), Design of Experiment (DoE).
However, pharmaceutical manufacturing is fundamentally different from ordinary industrial processes laid down in the Six Sigma approach. In this case, there is a strict need for compliance with the already established production process protocols, the product’s parameters approved by the authorities, as well as compliance with GMP requirements in the process. The application of Six Sigma helps enhance the existing system of pharmaceutical quality management but does not take its place.
For example, a tablet factory may observe that tablet weight is being changed often during tableting. The objective of the project may include finding out why many changes are made in weight and also improving the consistency of the process while working within acceptable in-process limits.
The project charter shall specify:
In the case of a tablet compression process, data may include tablet weight, compression force, speed of machine, speed of turret and frequency of tune-up, as it applies to the process.
Prior to analyzing the data, instruments calibration, measurement methods, sample-taking frequency and reliability of data must be confirmed. The measuring device which shows differently gives erroneous conclusions.
For instance, the variant of the weight of the tablet might be connected to powder flow, feeder settings, granule properties, machine work, and measuring practices.
Changes proposed for validated processes will be subject to the required change control process and assessments of their impact. Before implementation, improvements must be verified in terms of previously defined acceptance criteria.
A project should not be regarded as a success just because it gives good results in tests. The fact that there are no problems with using this improvement during regular operations.
For instance, a tablet production line may have a number of machine defects related to compression.
Thus, employees may encounter different types of problems:
It is worth mentioning that it is important to choose an appropriate design for each specific case. The most important type of deviation is not necessarily the most wide-spread one as it may turn out that less frequent deviations may lead to more serious losses.
For instance, if the capsule filling machine shows recurrent variations in fill weight, the operators would analyze the following aspects:
Man: Training and skills of the operator.
Machine: Parts of the machine, conditions of the machine and operating performance.
Method: Process of set up and processes.
Material: Powder flow, size of particles, and density.
Measurement: The device used for measurement, calibration of the device, and sampling.
Environment: The level of temperature and humidity if needed.
The diagram facilitates the process of evaluating the brainstorming session, however it does not validate the root cause. Each major assumption should be corroborated by evidence.
The 5 Whys method can investigate a particular causal pathway. If occurrences of machine failure take place repeatedly, a question may be posed regarding the grounding of the failure, the reasons for such condition and why detection or prevention failed.
In the process of investigating GMP, asking “why” is insufficient. A root cause must rest on evidence-backed conclusions, observations, tests and/or other objective evidence pieces.
Different control charts are used depending on specific situations. The following examples illustrate this point:
X-bar and R chart: For grouped continuous data
I-MR chart: For individual continuous data
p chart: For evaluating defectives in terms of proportions
c chart: For counting the number of defects when the number of inspection opportunities is stable
u chart: For counting defects per unit when the number of inspection opportunities is varied
In pharmaceutical production control charts can be used to monitor tablets’ weight, filling volume, temperatures during manufacture, or some indicators of laboratory operation, provided the specific chart is chosen depending on the data being analyzed.
Control limits are calculated on the basis of the process data and should not be confused with the specification limits. Specification limits are necessary to determine whether the product or the process meet expectations, while the control limits indicate what happens in the process.
Process stability does not necessarily result in compliance with specification limits, and compliance with specification limits does not mean process stability.
Two widely accepted indices used for this purpose are:
Cp: Determines potential capability of the process in terms of spread within specification limits.
Cpk: Determines capability by assessing both spread and the extent of centering of the process in relation to specification limits.
Any interpretation of these indices should be carried out with caution. Capability analysis can only give useful results if correct data and measurement systems are used and the process has achieved the desired level of stability.
As an example, a tablet weight procedure may show acceptable results, yet the process capability analysis may show that this process operates very near to one limit or specification. This should lead to an investigation of process centering or dispersion.
Cp and Cpk values do not eliminate the need to do the batch release testing or follow pharmacopoeial and approved specifications. They are just process indicators and cannot be considered as proof of batch acceptance.
Specifically, FMEA is used in the pharmaceutical industry to assess risks posed by the use of equipment, the process of manufacture, the packaging process, the laboratory workflow, and the utilities involved.
As an illustration, an assessment of the packaging line might have identified potential failure modes such as incorrect label placement, missing batch numbers, or barcode reading issues.
The seriousness of the effects, likelihood of occurrence, and detection capability of failure are assessed by the team using the company's approved risk methodology. Risk prioritization should guide the selection of the appropriate controls and actions.
FMEA is particularly valuable before introducing process improvements since it helps in evaluating whether a change proposed has introduced new risks. It should serve as an adjunct to, rather than replace, the pharmaceutical quality risk management process, so it does not turn into just a scoring exercise without significant technical assessment.
For example, granulation development can consist of many different parameters that can include the addition of the binder, the speed of the impeller, and the granulation time. The DoE will show how each of these parameters might influence granule characteristics and tablet yield.
In pharmacology, all experimental procedures must be scientifically justified and carried out according to the approved protocol. The design should contain factors and responses, ranges, criteria for acceptance, and the statistical analysis.
The DoE assists in understanding the processes, developing, and analyzing the processes. However, it does not give the right to change the approved commercial manufacturing parameters outside the set requirements, documentation assessment, and regulatory approval.
The quality team should also think about whether the issue requires a formal deviation inquiry, CAPA, change regulation, or any other widely used GMP process. Some Six Sigma instruments can help with this work; however, they will not be an alternative to the necessary documentation and approvals.
Six Sigma tools give the experts in the field of pharmacy useful techniques to comprehend variations in processes, identify defects, uncover the reason behind defects, and measure improvements made. Their usefulness comes from the use of dependable data and utilizing the correct method of analysis for the specific issue. When implemented according to GMP principles, they can help with process comprehension and consistency and yet do not diminish the established quality controls.
The approach has its techniques, such as DMAIC, SIPOC, Pareto analysis, fishbone diagrams, 5 Whys analysis, control charts, process capability tests, Failure Modes and Effects Analysis (FMEA), Design of Experiment (DoE).
However, pharmaceutical manufacturing is fundamentally different from ordinary industrial processes laid down in the Six Sigma approach. In this case, there is a strict need for compliance with the already established production process protocols, the product’s parameters approved by the authorities, as well as compliance with GMP requirements in the process. The application of Six Sigma helps enhance the existing system of pharmaceutical quality management but does not take its place.
1. DMAIC: A Structure for Six Sigma Projects
DMAIC refers to Define, Measure, Analyze, Improve, and Control. It presents a structured framework for the analysis and improvement of already running processes.1. Define
The Define phase defines the problem, scope of the project, objectives, and desired result. The problem has to be formulated using measurable operational indicators rather than general descriptions.For example, a tablet factory may observe that tablet weight is being changed often during tableting. The objective of the project may include finding out why many changes are made in weight and also improving the consistency of the process while working within acceptable in-process limits.
The project charter shall specify:
- The problem being solved and the process affected.
- The project limits and the people responsible for the project.
- The relevant indicators in terms of quality and activity.
- Improvement anticipated and the impact of product quality.
2. Measure
The Metric stage determines the present process performance. Data should be gathered through an accepted and consistent method of measurement.In the case of a tablet compression process, data may include tablet weight, compression force, speed of machine, speed of turret and frequency of tune-up, as it applies to the process.
Prior to analyzing the data, instruments calibration, measurement methods, sample-taking frequency and reliability of data must be confirmed. The measuring device which shows differently gives erroneous conclusions.
3. Analyze
The Analyze phase shows us the factors which have contributed to the existing problem. We need to conduct statistical analysis, process mapping, drawings of the Pareto diagrams and cause-and-effect diagrams that will help us differentiate important reasons from other possibilities.For instance, the variant of the weight of the tablet might be connected to powder flow, feeder settings, granule properties, machine work, and measuring practices.
4. Improve
The Improve step creates and assesses appropriate solutions in terms of machine settings, materials, processing, operator practices, and maintenance.Changes proposed for validated processes will be subject to the required change control process and assessments of their impact. Before implementation, improvements must be verified in terms of previously defined acceptance criteria.
5. Control
The Control step makes sure that improvements remain effective. Following this step, possible monitoring strategies, control charts, new SOPs for operators, and performance reviews will have to be developed.A project should not be regarded as a success just because it gives good results in tests. The fact that there are no problems with using this improvement during regular operations.
2. Pareto Analysis: Recognizing the Most Important Faults
One way of prioritizing issues is to employ Pareto analysis which shows which common types of problem cause most of failures or defects. The general idea behind this technique is that some problems or errors could account for most of the concerns.For instance, a tablet production line may have a number of machine defects related to compression.
Thus, employees may encounter different types of problems:
- Tablet weight variation.
- Capping and lamination.
- Sticking and picking.
- Hardness failures.
- Machine stoppages.
It is worth mentioning that it is important to choose an appropriate design for each specific case. The most important type of deviation is not necessarily the most wide-spread one as it may turn out that less frequent deviations may lead to more serious losses.
3. Utilization of a Fishbone Diagram and 5 Whys for Investigation of Root Causes
The Fishbone Diagram, also known as Ishikawa or Cause and Effect Diagram, depicts different potential causes of a problem in various categories. Common categories of manufacturing include Man, Machine, Method, Material, Measurement, and Environment.For instance, if the capsule filling machine shows recurrent variations in fill weight, the operators would analyze the following aspects:
Man: Training and skills of the operator.
Machine: Parts of the machine, conditions of the machine and operating performance.
Method: Process of set up and processes.
Material: Powder flow, size of particles, and density.
Measurement: The device used for measurement, calibration of the device, and sampling.
Environment: The level of temperature and humidity if needed.
The diagram facilitates the process of evaluating the brainstorming session, however it does not validate the root cause. Each major assumption should be corroborated by evidence.
The 5 Whys method can investigate a particular causal pathway. If occurrences of machine failure take place repeatedly, a question may be posed regarding the grounding of the failure, the reasons for such condition and why detection or prevention failed.
In the process of investigating GMP, asking “why” is insufficient. A root cause must rest on evidence-backed conclusions, observations, tests and/or other objective evidence pieces.
4. Control Charts: Monitoring the Stability of the Process
Control charts are statistical tools for monitoring changes in the process over time. Their purpose is to differentiate between normal variations of the process and changes indicating abnormal situations.Different control charts are used depending on specific situations. The following examples illustrate this point:
X-bar and R chart: For grouped continuous data
I-MR chart: For individual continuous data
p chart: For evaluating defectives in terms of proportions
c chart: For counting the number of defects when the number of inspection opportunities is stable
u chart: For counting defects per unit when the number of inspection opportunities is varied
In pharmaceutical production control charts can be used to monitor tablets’ weight, filling volume, temperatures during manufacture, or some indicators of laboratory operation, provided the specific chart is chosen depending on the data being analyzed.
Control limits are calculated on the basis of the process data and should not be confused with the specification limits. Specification limits are necessary to determine whether the product or the process meet expectations, while the control limits indicate what happens in the process.
Process stability does not necessarily result in compliance with specification limits, and compliance with specification limits does not mean process stability.
5. Process Capability Analysis: Assessing Consistency Relative to Specifications
Process capability analysis is a method to determine the degree to which a process operates within predetermined specification limits.Two widely accepted indices used for this purpose are:
Cp: Determines potential capability of the process in terms of spread within specification limits.
Cpk: Determines capability by assessing both spread and the extent of centering of the process in relation to specification limits.
Any interpretation of these indices should be carried out with caution. Capability analysis can only give useful results if correct data and measurement systems are used and the process has achieved the desired level of stability.
As an example, a tablet weight procedure may show acceptable results, yet the process capability analysis may show that this process operates very near to one limit or specification. This should lead to an investigation of process centering or dispersion.
Cp and Cpk values do not eliminate the need to do the batch release testing or follow pharmacopoeial and approved specifications. They are just process indicators and cannot be considered as proof of batch acceptance.
6. FMEA: Risk Management Prior to Adverse Events
The failure modes and effects analysis (FMEA) tool has been used as a way to proactively assess risks. The use of the tool allows for the determination of failure modes of hazards, including the identification of the possible consequences, causes, and controls already in place by the organization.Specifically, FMEA is used in the pharmaceutical industry to assess risks posed by the use of equipment, the process of manufacture, the packaging process, the laboratory workflow, and the utilities involved.
As an illustration, an assessment of the packaging line might have identified potential failure modes such as incorrect label placement, missing batch numbers, or barcode reading issues.
The seriousness of the effects, likelihood of occurrence, and detection capability of failure are assessed by the team using the company's approved risk methodology. Risk prioritization should guide the selection of the appropriate controls and actions.
FMEA is particularly valuable before introducing process improvements since it helps in evaluating whether a change proposed has introduced new risks. It should serve as an adjunct to, rather than replace, the pharmaceutical quality risk management process, so it does not turn into just a scoring exercise without significant technical assessment.
7. Design of Experiments: Understand the Effect of Process Variables
Design of Experiments (DoE) is an analytical procedure for determining how many factors affect the reactions of a process. The traditional way of changing only one factor can significantly underplay the effect of each factor on the response.For example, granulation development can consist of many different parameters that can include the addition of the binder, the speed of the impeller, and the granulation time. The DoE will show how each of these parameters might influence granule characteristics and tablet yield.
In pharmacology, all experimental procedures must be scientifically justified and carried out according to the approved protocol. The design should contain factors and responses, ranges, criteria for acceptance, and the statistical analysis.
The DoE assists in understanding the processes, developing, and analyzing the processes. However, it does not give the right to change the approved commercial manufacturing parameters outside the set requirements, documentation assessment, and regulatory approval.
Choosing an Appropriate Six Sigma Tool for Solving the Problem
Not all quality issues need a complicated statistical study. The instrument should correspond to the issue.| Manufacturing or quality issue | Helpful tool |
| Constant deviations within one category | Pareto analysis |
| Uncertain possible reasons of the issue | Fishbone diagram and 5 Whys |
| Changes in the process over time | Control charts |
| Parameters against specified limits | Process capability analysis |
| Possible malfunction before use | FMEA |
| Many interacting process variables | DoE |
| Large process improvement initiative | DMAIC |
The quality team should also think about whether the issue requires a formal deviation inquiry, CAPA, change regulation, or any other widely used GMP process. Some Six Sigma instruments can help with this work; however, they will not be an alternative to the necessary documentation and approvals.
Six Sigma tools give the experts in the field of pharmacy useful techniques to comprehend variations in processes, identify defects, uncover the reason behind defects, and measure improvements made. Their usefulness comes from the use of dependable data and utilizing the correct method of analysis for the specific issue. When implemented according to GMP principles, they can help with process comprehension and consistency and yet do not diminish the established quality controls.


No comments:
Post a Comment
Please don't spam. Comments having links would not be published.